Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 4.130
0.00 (0.00%)
At close: Mar 27, 2026
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 800.6 million as of March 27, 2026. Its market cap has decreased by -18.86% in one year.
Market Cap
800.60M
Enterprise Value
790.17M
Revenue
74.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.13
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 800.60M, a decrease of -74.07%. That is a compound annual growth rate of -41.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 800.60M | -48.50% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.56B |
| Kintor Pharmaceutical | 1.44B |
| Beijing Biostar Pharmaceuticals | 1.39B |
| Transcenta Holding | 1.15B |
| 3D Medicines | 1.03B |
| Brii Biosciences | 1.01B |
| Sunho Biologics | 970.43M |
| Shanghai Bio-heart Biological Technology | 963.93M |